Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as ... - Markets Insider

Submitted by Anonymous (not verified) on Tue, 06/18/2024 - 11:56

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as ...  Markets Insider